| Five years in figures, MEUR | |||||
|---|---|---|---|---|---|
| 2024 | 2023 | 2022 | 2021 | 2020 | |
| Net sales | 6,449 | 6,015 | 5,842 | 4,778 | 4,604 |
| of which outside Finland, % | 98.4 | 98.3 | 99.2 | 98.5 | 97.9 |
| Exports from Finland | 2,466 | 2,060 | 1,975 | 1,845 | 1,702 |
| Personnel on average | 18,110 | 17,666 | 17,482 | 17,461 | 18,307 |
| of which in Finland | 4,187 | 3,957 | 3,808 | 3,687 | 3,706 |
| Order book | 8,366 | 6,694 | 5,906 | 5,859 | 5,057 |
| From the consolidated statement of income | |||||
| 2024 | 2023 | 2022 | 2021 | 2020 | |
| Depreciation, amortisation and impairment | 131 | 193 | 263 | 162 | 174 |
| Share of result of associates and joint ventures | 12 | 9 | 6 | 3 | 3 |
| Comparable operating result | 694 | 497 | 325 | 357 | 275 |
| as a percentage of net sales, % | 10.8 | 8.3 | 5.6 | 7.5 | 6.0 |
| Operating result | 716 | 402 | -26 | 314 | 234 |
| as a percentage of net sales, % | 11.1 | 6.7 | -0.4 | 6.6 | 5.1 |
| Comparable adjusted EBITA | 712 | 518 | 349 | 388 | 308 |
| as a percentage of net sales, % | 11.0 | 8.6 | 6.0 | 8.1 | 6.7 |
| Financial income and expenses | -29 | -37 | -6 | -18 | -43 |
| Result before taxes | 687 | 364 | -32 | 296 | 191 |
| as a percentage of net sales, % | 10.7 | 6.1 | -0.5 | 6.2 | 4.2 |
| Result for the financial period | 507 | 269 | -59 | 193 | 133 |
| as a percentage of net sales, % | 7.9 | 4.5 | -1.0 | 4.0 | 2.9 |
| From the consolidated statement of financial position | |||||
| 2024 | 2023 | 2022 | 2021 | 2020 | |
| Non-current assets | 2,581 | 2,551 | 2,556 | 2,539 | 2,427 |
| Current assets | 4,928 | 4,247 | 3,997 | 3,982 | 3,706 |
| Assets held for sale | 184 | 5 | 54 | 2 | 99 |
| Total equity attributable to equity holders of the parent company | 2,525 | 2,225 | 2,135 | 2,315 | 2,177 |
| Non-controlling interests | 6 | 8 | 12 | 8 | 11 |
| Interest-bearing debt | 766 | 858 | 949 | 973 | 1,327 |
| Non interest-bearing liabilities | 4,264 | 3,713 | 3,489 | 3,227 | 2,648 |
| Liabilities directly attributable to assets held for sale | 132 | - | 22 | - | 68 |
| Total equity and liabilities | 7,694 | 6,803 | 6,606 | 6,523 | 6,232 |
| From the consolidated statement of cash flows | |||||
| 2024 | 2023 | 2022 | 2021 | 2020 | |
| Cash flow from operating activities | 1,208 | 822 | -62 | 731 | 681 |
| Cash flow from investing activities | -149 | -138 | -151 | -128 | -55 |
| Cash flow from financing activities | -323 | -308 | -289 | -580 | -44 |
| Gross capital expenditure | 170 | 149 | 161 | 143 | 117 |
| as percentage of net sales, % | 2.6 | 2.5 | 2.8 | 3.0 | 2.5 |
| Research and development expenses | 296 | 258 | 241 | 196* | 153 |
| as percentage of net sales, % | 4.6 | 4.3 | 4.1 | 4.1* | 3.3 |
| Dividends paid | 259** | 188 | 153 | 142 | 118 |
| Financial ratios | |||||
| 2024 | 2023 | 2022 | 2021 | 2020 | |
| Earnings per share, basic and diluted (EPS), EUR | 0.85 | 0.44 | -0.11 | 0.33 | 0.23 |
| Dividend per share, EUR | 0.85 | 0.32 | -0.11 | 0.24 | 0.20 |
| Dividend per earnings, % | 0.44** | 73.2 | 0.26 | 73.2 | 88.2 |
| Interest coverage | 51.5** | 9.2 | -234.9 | 15.0 | 7.1 |
| Return on investment (ROI), % | 12.3 | 13.9 | 7.3 | 9.7 | 7.1 |
| Return on equity (ROE), % | 23.7 | 12.3 | 0.1 | 8.6 | 5.8 |
| Solvency ratio, % | 21.3 | 37.0 | -2.6 | 38.6 | 38.1 |
| Gearing | -0.31 | 0.02 | 0.23 | 0.00 | 0.18 |
| Equity per share, EUR | 4.29 | 3.78 | 3.62 | 3.92 | 3.68 |
| Working capital (WCAP), EUR | -787 | -169 | 179 | -100 | 257 |
The financial ratios include assets and liabilities pertaining to assets held for sale.
* Figure in the comparison period 2021 has been restated to reflect a change in the definition of research and development expenditure.
** Proposal of the Board of Directors.
Related information:
Calculation of financial ratios